Alzheimer Disease Familial  >>  verubecestat (MK-8931)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
verubecestat (MK-8931) / Merck (MSD)
NCT01496170: A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])

Checkmark
Nov 2016 - Nov 2016: 
Checkmark ADI 2016
Apr 2016 - Apr 2016: ADI 2016
Checkmark Mild-to-moderate Alzheimer's disease (AAIC 2013)
More
Completed
1b
32
US
MK-8931, SCH 900931, Placebo
Merck Sharp & Dohme LLC
Alzheimer's Disease
06/12
06/12
NCT01537757: A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])

Completed
1
12
US
MK-8931
Merck Sharp & Dohme LLC
Alzheimer's Disease
05/12
05/12

Download Options